Electroconvulsive therapy - Indications and practical use for pharmacotherapy resistant depressive disorders;Elektrokonvulsionstherapie - Indikationsstellung und Durchführung bei pharmakotherapieresistenten psychiatrischen Erkrankungen

Fortschritte der Neurologie Psychiatrie

Volumn 80, Issue 12, 2012, Pages 720-731

  Baghai, T C ^a   Lieb, M ^a   Rupprecht, R ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEPRESSION; ELECTROCONVULSIVE THERAPY; TREATMENT FAILURE; TREATMENT INDICATION;

ACUTE DISEASE; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY DISORDERS; RECURRENCE; SCHIZOPHRENIA;

EID: 84870740770     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0032-1325607     Document Type: Article

References (84)

1. Diazgranados N., Ibrahim L., Brutsche N. E. et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry: 2010; 67 08 793 802
2. Zarate C. A. Jr, Singh J. B., Carlson P. J. et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry: 2006; 63 08 856 864
3. Mathew S. J., Shah A., Lapidus K. et al. Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs: 2012; 26 03 189 204
4. World Health Organization WHO resource book on mental health, human rights and legislation. 2005
5. Chanpattana W., Kramer B. A., Kunigiri G. et al. A survey of the practice of electroconvulsive therapy in Asia. J ECT: 2010; 26 01 5 10
6. Leiknes K. A., Jarosh-von S. L., Hoie B. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav: 2012; 2 03 283 344
7. Scharfetter J., Frey R., Kasper S. Biologische Grundlagen der Elektrokonvulsionstherapie. In: Baghai T. C., Frey R., Kasper S. et al. (Hrsg) Elektrokonvulsionstherapie - Klinische und wissenschaftliche Aspekte. Wien, New York Springer: 2004; 87 105
8. Holtzmann J., Polosan M., Baro P. et al. ECT: from neuronal plasticity to mechanisms underlying antidepressant medication effect. Encephale: 2007; 33 04 572 578
9. Taylor S. M. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT: 2008; 24 02 160 165
10. Gedge L., Beaudoin A., Lazowski L. et al. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry: 2012; 3 12
11. Loh N., Nickl-Jockschat T., Sheldrick A. J. et al. Accessibility, standards and challenges of electroconvulsive therapy in Western industrialized countries: A German example. World J Biol Psychiatry: 2012; 10.3109/15622975. 2012.665176
12. Bustin J., Rapoport M. J., Krishna M. et al. Are patients' attitudes towards and knowledge of electroconvulsive therapy transcultural? A multi-national pilot study. Int J Geriatr Psychiatry: 2008; 23 05 497 503
13. Rajagopal R., Chakrabarti S., Grover S. et al. Knowledge, experience & attitudes concerning electroconvulsive therapy among patients & their relatives. Indian J Med Res: 2012; 135 201 210
14. Gangadhar B. N., Kapur R. L., Kalyanasundaram S. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study. Br J Psychiatry: 1982; 141 367 371
15. Rothschild A. J. Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am: 1996; 19 02 237 252
16. Sauer H., Lauter H. Electroconvulsive therapy. II. Indications, contraindications and therapeutic technics of electroconvulsive therapy. Nervenarzt: 1987; 58 04 210 218
17. Prudic J., Haskett R. F., Mulsant B. et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry: 1996; 153 08 985 992
18. Sackeim H. A. The definition and meaning of treatment-resistant depression. J Clin Psychiatry: 2001; 62 16 10 17
19. Sartorius N., Baghai T. C., Baldwin D. S. et al. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol: 2007; 10 01 S1 S207
20. Stassen H. H., Angst J. Delayed Onset of Action of Antidepressants - Fact or Fiction? CNS Drugs: 1998; 9 03 177 184
21. Szegedi A., Jansen W. T., van Willigenburg A. P. et al. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry: 2009; 70 03 344 353
22. Folkerts H. W., Michael N., Tolle R. et al. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression - a randomized study. Acta Psychiatr Scand: 1997; 96 05 334 342
23. Flint A. J., Rifat S. L. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry: 1998; 13 01 23 28
24. McCall W. V. Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol: 2001; 4 03 315 324
25. Rabheru K. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how? J ECT: 2012; 28 01 39 47
26. Frey R., Schreinzer D., Heiden A. et al. Use of electroconvulsive therapy in psychiatry. Nervenarzt: 2001; 72 09 661 676
27. Pfennig A., Bschor T., Baghai T. et al. S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations. Nervenarzt: 2012; 83 05 568 586
28. Grunze H., Schlosser S., Walden J. New perspectives in the acute treatment of bipolar depression. World J Biol Psychiatry: 2000; 1 03 129 136
29. DeQuardo J. R., Tandon R. Concurrent lithium therapy prevents ECT-induced switch to mania. J Clin Psychiatry: 1988; 49 04 167 168
30. Aarre T. F., Bugge P. ECT for patients taking lamotrigine. Eur Psychiatry: 2002; 17 01 135
31. Zarate C. A. Jr, Tohen M., Baraibar G. Combined valproate or carbamazepine and electroconvulsive therapy. Ann Clin Psychiatry: 1997; 9 01 19 25
32. Weiner R. D., Coffey C. E., Folk J. et al. The Practice of Electroconvulsive Therapy. 2nd ed Washington American Psychiatric Association: 2001
33. Greenblatt M., Grosser G. H., Wechsler H. A. Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry: 1964; 120 935 943
34. McDonald I. M., Perkins M., Marjerrison G. et al. A controlled comparison of amitriptyline and electroconvulsive therapy in the treatment of depression. Am J Psychiatry: 1966; 122 12 1427 1431
35. Janicak P. G., Davis J. M., Gibbons R. D. et al. Efficacy of ECT: a meta-analysis. Am J Psychiatry: 1985; 142 03 297 302
36. Rifkin A. ECT versus tricyclic antidepressants in depression: a review of the evidence. J Clin Psychiatry: 1988; 49 01 3 7
37. Prudic J., Sackeim H. A., Devanand D. P. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res: 1990; 31 03 287 296
38. Dinan T. G., Barry S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand: 1989; 80 01 97 100
39. Sonawalla S. B., Fava M. Severe depression: is there a best approach? CNS Drugs: 2001; 15 10 765 776
40. Kopecek M., Cerna L., Sulak J. et al. Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy. Neuro Endocrinol Lett: 2007; 28 06 889 894
41. Baghai T. C., Marcuse A., Brosch M. et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World Journal of Biological Psychiatry In press
42. Sackeim H. A., Prudic J., Devanand D. P. et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry: 2000; 57 05 425 434
43. Quitkin F. M., McGrath P. J., Stewart J. W. et al. Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology: 1996; 15 04 390 394
44. Nobler M. S., Sackeim H. A., Moeller J. R. et al. Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. Convuls Ther: 1997; 13 04 208 221
45. Nothdurfter C., Eser D., Schule C. et al. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry: 2006; 7 03 162 170
46. Lehman A. F., Lieberman J. A., Dixon L. B. et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry: 2004; 161 02 1 56
47. American Psychiatric Association The Practice of ECT: Recommendations for Treatment, Training and Privileging. Convuls Ther: 1990; 6 02 85 120
48. Lehnhardt F. G., Konkol C., Kuhn J. Use of ECT in Drug-Refractory Schizophrenia - A Survey of the Current Literature. Fortschr Neurol Psychiatr: 2012; 80 501 511
49. Beale M. D., Kellner C. H., Pritchett J. T. et al. ECT for OCD. J Clin Psychiatry: 1995; 56 02 81 82
50. Rabheru K., Persad E. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry: 1997; 42 05 476 484
51. Sareen J., Enns M. W., Guertin J. E. The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy. J ECT: 2000; 16 01 43 51
52. Zorumski C. F., Rutherford J. L., Burke W. J. et al. ECT in primary and secondary depression. J Clin Psychiatry: 1986; 47 06 298 300
53. Murray G. B., Shea V., Conn D. K. Electroconvulsive therapy for poststroke depression. J Clin Psychiatry: 1986; 47 05 258 260
54. Hackett M. L., Anderson C. S., House A. et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev: 2008; 4 CD003437
55. Oudman E. Is electroconvulsive therapy (ECT) effective and safe for treatment of depression in dementia? A short review. J ECT: 2012; 28 01 34 38
56. Abrams R. Electroconvulsive Therapy. 4th ed Oxford, New York Oxford University Press: 2002
57. Baghai T. C., Eser D., Schüle C. et al. Elektrokonvulsionstherapie bei depressiven Störungen. Journal für Neurologie, Neurochirurgie und Psychiatrie: 2005; 4 20 28
58. Abrams R. The mortality rate with ECT. Convuls Ther: 1997; 13 03 125 127
59. Shiwach R. S., Reid W. H., Carmody T. J. An analysis of reported deaths following electroconvulsive therapy in Texas, 1993-1998. Psychiatr Serv: 2001; 52 08 1095 1097
60. Dersch R., Zwernemann S., Voderholzer U. Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion. Pharmacopsychiatry: 2011; 44 07 344 346
61. Kamel H., Cornes S. B., Hegde M. et al. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care: 2010; 12 02 204 210
62. Pogarell O., Ehrentraut S., Ruther T. et al. Prolonged confusional state following electroconvulsive therapy - diagnostic clues from serial electroencephalography. Pharmacopsychiatry: 2005; 38 06 316 320
63. Fink M. Interseizure EEG Slowing after ECT is not NCSE. Pharmacopsychiatry: 2006; 39 03 119
64. Reimherr F. W., Hodges M. R., Hill G. E. et al. Prolongation of muscle relaxant effects by lithium carbonate. Am J Psychiatry: 1977; 134 02 205 206
65. Markowitz J. S., Kellner C. H., DeVane C. L. et al. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT: 2001; 17 04 280 283
66. Calev A., Gaudino E. A., Squires N. K. et al. ECT and non-memory cognition: a review. Br J Clin Psychol: 1995; 34 04 505 515
67. Lisanby S. H., Maddox J. H., Prudic J. et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry: 2000; 57 06 581 590
68. Semkovska M., McLoughlin D. M. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry: 2010; 68 06 568 577
69. Devanand D. P., Fitzsimons L., Prudic J. et al. Subjective side effects during electroconvulsive therapy. Convuls Ther: 1995; 11 04 232 240
70. Calev A., Nigal D., Shapira B. et al. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. J Nerv Ment Dis: 1991; 179 09 526 533
71. Krystal A. D., Coffey C. E. Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci: 1997; 9 02 283 292
72. Delva N. J., Brunet D., Hawken E. R. et al. Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. J ECT: 2000; 16 04 361 369
73. Ng C., Schweitzer I., Alexopoulos P. et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J ECT: 2000; 16 04 370 379
74. Cohen D., Taieb O., Flament M. et al. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry: 2000; 157 03 460 462
75. Pettinati H. M., Bonner K. M. Cognitive functioning in depressed geriatric patients with a history of ECT. Am J Psychiatry: 1984; 141 01 49 52
76. Agelink M. W., Andrich J., Postert T. et al. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry: 2001; 71 03 394 396
77. ECT review group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet: 2003; 361 9360 799 808
78. Sackeim H. A., Prudic J., Devanand D. P. et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med: 1993; 328 12 839 846
79. Ostroff R., Gonzales M., Sanacora G. Antidepressant effect of ketamine during ECT. Am J Psychiatry: 2005; 162 07 1385 1386
80. Okamoto N., Nakai T., Sakamoto K. et al. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT: 2010; 26 03 223 227
81. Viswanath B., Narayanaswamy J. C., Thirthalli J. et al. Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT. Indian J Psychol Med: 2011; 33 01 66 70
82. Eschweiler G. W., Vonthein R., Bode R. et al. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression. J Affect Disord: 2007; 101 01 149 157
83. Sienaert P. Bifrontal, bitemporal and right unilateral ECT electrode placement are similarly effective for reducing depressive symptoms. Evid Based Ment Health: 2010; 13 03 85
84. Quante A., Luborzewski A., Brakemeier E. L. et al. Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study. J Psychiatr Res: 2011; 45 02 174 178